<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36605593</PMID><DateRevised><Year>2023</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1976-8354</ISSN><JournalIssue CitedMedium="Print"><Volume>26</Volume><Issue>6</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Animal cells and systems</Title><ISOAbbreviation>Anim Cells Syst (Seoul)</ISOAbbreviation></Journal><ArticleTitle>Metabolic reprogramming as a novel therapeutic target for Coxsackievirus B3.</ArticleTitle><Pagination><StartPage>275</StartPage><EndPage>282</EndPage><MedlinePgn>275-282</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/19768354.2022.2141318</ELocationID><Abstract><AbstractText>Coxsackievirus B3 (CVB3) is a single-stranded RNA virus that belongs to the <i>Enterovirus</i> genus. CVB3 is a human pathogen associated with serious conditions such as myocarditis, dilated cardiomyopathy, and pancreatitis. However, there are no therapeutic interventions to treat CVB3 infections. In this study, we found that CVB3 induced metabolic alteration in host cells through increasing glycolysis level, as indicated by an increase in the extracellular acidification rate (ECAR). CVB3-mediated metabolic alteration was confirmed by metabolite change analysis using gas chromatography-mass spectrometry (GC-MS). Based on findings, a strategy to inhibit glycolysis has been proposed to treat CVB3 infection. Indeed, glycolysis inhibitors (2-Deoxy-D-glucose, sodium oxide) significantly reduced CVB3 titers after CVB3 infection, indicating that glycolysis inhibitors can be used as effective antiviral agents. Taken together, our results reveal a novel mechanism by which CVB3 infection is controlled by regulation of host cell metabolism.</AbstractText><CopyrightInformation>© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kuk</LastName><ForeName>Myeong Uk</ForeName><Initials>MU</Initials><AffiliationInfo><Affiliation>Division of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ga</LastName><ForeName>Yun Ji</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Division of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ye Jin</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Division of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Ji Yun</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Division of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Eun Seon</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Division of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Haneur</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yun Haeng</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Division of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Gahyun</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jae Kwang</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Division of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeh</LastName><ForeName>Jung-Yong</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Division of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwon</LastName><ForeName>Hyung Wook</ForeName><Initials>HW</Initials><Identifier Source="ORCID">0000-0001-9340-7974</Identifier><AffiliationInfo><Affiliation>Division of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Convergence Research Center for Insect Vectors, Incheon National University, Incheon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Byun</LastName><ForeName>Youngjoo</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-0297-7734</Identifier><AffiliationInfo><Affiliation>College of Pharmacy, Korea University, Sejong, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Joon Tae</ForeName><Initials>JT</Initials><Identifier Source="ORCID">0000-0003-2396-9108</Identifier><AffiliationInfo><Affiliation>Division of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Convergence Research Center for Insect Vectors, Incheon National University, Incheon, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Anim Cells Syst (Seoul)</MedlineTA><NlmUniqueID>101478641</NlmUniqueID><ISSNLinking>1976-8354</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coxsackievirus B3</Keyword><Keyword MajorTopicYN="N">antiviral effect</Keyword><Keyword MajorTopicYN="N">glycolysis inhibitors</Keyword><Keyword MajorTopicYN="N">metabolic alteration</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>6</Day><Hour>2</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36605593</ArticleId><ArticleId IdType="pmc">PMC9809346</ArticleId><ArticleId IdType="doi">10.1080/19768354.2022.2141318</ArticleId><ArticleId IdType="pii">2141318</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abrantes JL, Alves CM, Costa J, Almeida FC, Sola-Penna M, Fontes CF, Souza TM.. 2012. Herpes simplex type 1 activates glycolysis through engagement of the enzyme 6-phosphofructo-1-kinase (PFK-1). Biochimica et Biophysica Acta. Aug. 1822:1198–1206. Epub 2012/05/01.</Citation><ArticleIdList><ArticleId IdType="pubmed">22542512</ArticleId></ArticleIdList></Reference><Reference><Citation>Barr JN, Fearns R.. 2016. Genetic instability of RNA viruses. Genome Stability. 2016:21–35. Epub 2016/09/09.</Citation></Reference><Reference><Citation>Barrero CA, Datta PK, Sen S, Deshmane S, Amini S, Khalili K, Merali S.. 2013. HIV-1 Vpr modulates macrophage metabolic pathways: a SILAC-based quantitative analysis. PLoS One. 8:e68376. Epub 2013/07/23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3709966</ArticleId><ArticleId IdType="pubmed">23874603</ArticleId></ArticleIdList></Reference><Reference><Citation>Brand MD, Nicholls DG.. 2011. Assessing mitochondrial dysfunction in cells. Biochem J. 435:297–312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3076726</ArticleId><ArticleId IdType="pubmed">21726199</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassim S, Raymond VA, Dehbidi-Assadzadeh L, Lapierre P, Bilodeau M.. 2018. Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment. Cell Cycle (Georgetown, Tex). 17:903–916. Epub 2018/04/11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6056217</ArticleId><ArticleId IdType="pubmed">29633904</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavallari I, Scattolin G, Silic-Benussi M, Raimondi V, D'Agostino DM, Ciminale V.. 2018. Mitochondrial proteins coded by human tumor viruses. Front Microbiol. 9:81–81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5808139</ArticleId><ArticleId IdType="pubmed">29467726</ArticleId></ArticleIdList></Reference><Reference><Citation>Codo AC, Davanzo GG, Monteiro LB, de Souza GF, Muraro SP, Virgilio-da-Silva JV, Prodonoff JS, Carregari VC, de Biagi Junior CAO, Crunfli F, et al. . 2020. Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1α/glycolysis-dependent axis. Cell Metabolism. Sep. 1(32):437–446. e435. Epub 2020/07/23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7367032</ArticleId><ArticleId IdType="pubmed">32697943</ArticleId></ArticleIdList></Reference><Reference><Citation>Garmaroudi FS, Marchant D, Hendry R, Luo H, Yang D, Ye X, Shi J, McManus BM.. 2015. Coxsackievirus B3 replication and pathogenesis. Future Microbiol. 10:629–653. Epub 2015/04/14.</Citation><ArticleIdList><ArticleId IdType="pubmed">25865198</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S, Kass GEN, Szegezdi E, Joseph B.. 2009. The mitochondrial death pathway: a promising therapeutic target in diseases. J Cell Mol Med. 13:1004–1033. Epub 2009/02/09.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4496101</ArticleId><ArticleId IdType="pubmed">19220575</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen IL, Levy MM, Kerr DS.. 1984. The 2-deoxyglucose test as a supplement to fasting for detection of childhood hypoglycemia. Pediatric Research. Apr. 18:359–364. Epub 1984/04/01.</Citation><ArticleIdList><ArticleId IdType="pubmed">6718093</ArticleId></ArticleIdList></Reference><Reference><Citation>Icard P, Lincet H, Wu Z, Coquerel A, Forgez P, Alifano M, Fournel L.. 2021. The key role of Warburg effect in SARS-CoV-2 replication and associated inflammatory response. Biochimie. 180:169–177. Epub 2020/11/12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7659517</ArticleId><ArticleId IdType="pubmed">33189832</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JW, Kuk MU, Choy HE, Park SC, Park JT.. 2019. Mitochondrial metabolic reprograming via BRAF inhibition ameliorates senescence. Exp Gerontol. 126:110691. Epub 2019/08/20.</Citation><ArticleIdList><ArticleId IdType="pubmed">31421186</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim TJ, Choi J, Kim KW, Ahn SK, Ha S-H, Choi Y, Park NI, Kim JK.. 2017. Metabolite profiling of peppers of various colors reveals relationships between tocopherol, carotenoid, and phytosterol content. J Food Sci. 82:2885–2893.</Citation><ArticleIdList><ArticleId IdType="pubmed">29125620</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozach P-Y. 2020. Cell biology of viral infections. Cells. 9:2431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7694952</ArticleId><ArticleId IdType="pubmed">33171736</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Altamirano MMB, Kolstoe SE, Sánchez-García FJ.. 2019. Virus control of cell metabolism for replication and evasion of host immune responses. Front Cell Infect Microbiol. 9:95–95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6482253</ArticleId><ArticleId IdType="pubmed">31058096</ArticleId></ArticleIdList></Reference><Reference><Citation>Munger J, Bajad SU, Coller HA, Shenk T, Rabinowitz JD.. 2006. Dynamics of the cellular metabolome during human cytomegalovirus infection. PLoS Pathog. Dec. 2:e132. Epub 2006/12/19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1698944</ArticleId><ArticleId IdType="pubmed">17173481</ArticleId></ArticleIdList></Reference><Reference><Citation>Park C, Choi SH, Jeong JW, Han MH, Lee H, Hong SH, Kim GY, Moon SK, Kim WJ, Choi YH.. 2020. Honokiol ameliorates oxidative stress-induced DNA damage and apoptosis of c2c12 myoblasts by ROS generation and mitochondrial pathway. Animal Cells Syst (Seoul). 24:60–68. Epub 2020/03/12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7048179</ArticleId><ArticleId IdType="pubmed">32158617</ArticleId></ArticleIdList></Reference><Reference><Citation>Park C, Jeong JW, Han MH, Lee H, Kim GY, Jin S, Park JH, Kwon HJ, Kim BW, Choi YH.. 2021. The anti-cancer effect of betulinic acid in u937 human leukemia cells is mediated through ROS-dependent cell cycle arrest and apoptosis. Animal Cells Syst (Seoul). 25:119–127. Epub 2021/07/09.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8118407</ArticleId><ArticleId IdType="pubmed">34234893</ArticleId></ArticleIdList></Reference><Reference><Citation>Passalacqua KD, Lu J, Goodfellow I, Kolawole AO, Arche JR, Maddox RJ, Carnahan KE, O'Riordan MXD, Wobus CE.. 2019. Glycolysis Is an intrinsic factor for optimal replication of a norovirus. mBio. 10:e02175–e02118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6414699</ArticleId><ArticleId IdType="pubmed">30862747</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao T, Xiong Y, Feng Y, Guo W, Zhou Y, Zhao J, Jiang T, Shi C, Han Y.. 2021. Inhibition of LDH-A by oxamate enhances the efficacy of anti-PD-1 treatment in an NSCLC humanized mouse model. Front Oncol. 30:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8042335</ArticleId><ArticleId IdType="pubmed">33859941</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripoli M, D'Aprile A, Quarato G, Sarasin-Filipowicz M, Gouttenoire J, Scrima R, Cela O, Boffoli D, Heim MH, Moradpour D, et al. . 2010. Hepatitis C virus-linked mitochondrial dysfunction promotes hypoxia-inducible factor 1 alpha-mediated glycolytic adaptation. Journal of Virology. Jan. 84:647–660. Epub 2009/10/23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2798449</ArticleId><ArticleId IdType="pubmed">19846525</ArticleId></ArticleIdList></Reference><Reference><Citation>Song N, Jeong DY, Tu TH, Park BS, Yang HR, Kim YJ, Kim JK, Park JT, Yeh J-Y, Yang S, et al. . 2021. Adiponectin controls nutrient availability in hypothalamic astrocytes. Int J Mol Sci. 22:1587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7915184</ArticleId><ArticleId IdType="pubmed">33557390</ArticleId></ArticleIdList></Reference><Reference><Citation>Strandberg AY, Pienimäki T, Pitkälä KH, Tilvis RS, Salomaa VV, Strandberg TE.. 2013. Comparison of Normal fasting and one-hour glucose levels as predictors of future diabetes during a 34-year follow-up. Annals of Medicine. Jun. 45:336–340. Epub 2013/05/22.</Citation><ArticleIdList><ArticleId IdType="pubmed">23688029</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaker SK, Ch’ng J, Christofk HR.. 2019. Viral hijacking of cellular metabolism. BMC Biol. 18:17–59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6637495</ArticleId><ArticleId IdType="pubmed">31319842</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang A, Huen SC, Luan HH, Yu S, Zhang C, Gallezot JD, Booth CJ, Medzhitov R.. 2016. Opposing effects of fasting metabolism on tissue tolerance in bacterial and viral inflammation. Cell. . 166:1512–1525. e1512. Epub 2016/09/10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5555589</ArticleId><ArticleId IdType="pubmed">27610573</ArticleId></ArticleIdList></Reference><Reference><Citation>Weckmann K, Diefenthäler P, Baeken MW, Yusifli K, Turck CW, Asara JM, Behl C, Hajieva P.. 2018. Metabolomics profiling reveals differential adaptation of major energy metabolism pathways associated with autophagy upon oxygen and glucose reduction. Sci Rep. 8:2337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5799166</ArticleId><ArticleId IdType="pubmed">29402948</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong J, Zhang J, Si X, Gao G, Mao I, McManus BM, Luo H.. 2008. Autophagosome supports coxsackievirus B3 replication in host cells. Journal of Virology. Sep. 82:9143–9153. Epub 2008/07/04.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2546883</ArticleId><ArticleId IdType="pubmed">18596087</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao H, Li S, Zhang D, Liu T, Yu M, Wang F.. 2013. Separate and concurrent use of 2-deoxy-D-glucose and 3-bromopyruvate in pancreatic cancer cells. Oncology Reports. 29:329–334. Epub 2012/10/19.</Citation><ArticleIdList><ArticleId IdType="pubmed">23076497</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamasaki T, Tran TAT, Oz OK, Raj GV, Schwarz RE, Deberardinis RJ, Zhang X, Brugarolas J.. 2011. Exploring a glycolytic inhibitor for the treatment of an FH-deficient type-2 papillary RCC. Nat Rev Urol. 8:165–171. Epub 2011/02/08.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3055922</ArticleId><ArticleId IdType="pubmed">21304509</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D, Li J, Wang F, Hu J, Wang S, Sun Y.. 2014. 2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy. Cancer Letters. Dec. 28(355):176–183. Epub 2014/09/15.</Citation><ArticleIdList><ArticleId IdType="pubmed">25218591</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Wang G, Xu Z-G, Tu H, Hu F, Dai J, Chang Y, Chen Y, Lu Y, Zeng H, et al. . 2019. Lactate Is a natural suppressor of RLR signaling by targeting MAVS. Cell. 178:176–189..e115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6625351</ArticleId><ArticleId IdType="pubmed">31155231</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L, He R, Fang P, Li M, Yu H, Wang Q, Yu Y, Wang F, Zhang Y, Chen A, et al. . 2021. Hepatitis B virus rigs the cellular metabolome to avoid innate immune recognition. Nat Commun. 12:98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7782485</ArticleId><ArticleId IdType="pubmed">33397935</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>